Magenta Therapeutics, Inc. (MGTA) financial statements (2021 and earlier)

Company profile

Business Address 100 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments149146143
Cash and cash equivalents586558
Short-term investments918184
Other undisclosed current assets343
Total current assets:152150145
Noncurrent Assets
Property, plant and equipment81010
Restricted cash and investments222
Total noncurrent assets:101212
TOTAL ASSETS:162162157
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111410
Accounts payable433
Accrued liabilities8117
Total current liabilities:111410
Noncurrent Liabilities
Liabilities, other than long-term debt66 
Deferred rent credit66 
Other undisclosed noncurrent liabilities  1
Total noncurrent liabilities:661
Total liabilities:182012
Stockholders' equity
Stockholders' equity attributable to parent144141146
Common stock000
Additional paid in capital398321248
Accumulated other comprehensive income (loss)(0)0(0)
Accumulated deficit(254)(179)(103)
Total stockholders' equity:144141146
TOTAL LIABILITIES AND EQUITY:162162157

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(79)(83)(60)
Operating loss:(79)(83)(60)
Nonoperating income (expense)(0)12
Investment income, nonoperating(0)10
Loss before gain (loss) on sale of properties:(79)(82)(58)
Other undisclosed net income45 
Net loss attributable to parent:(75)(77)(58)
Preferred stock dividends and other adjustments  (0)
Net loss available to common stockholders, diluted:(75)(77)(58)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(75)(77)(58)
Comprehensive loss:(75)(77)(58)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(75)(77)(58)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: